In this article (Clin Cancer Res 2014;20:5908–17), which was published in the December 1, 2014, issue of Clinical Cancer Research (1), one of the authors' names was misprinted. The corrected name should read as follows: “Aurelius Omlin.” The publisher regrets this error.
- ©2015 American Association for Cancer Research.
Reference
- 1.↵
February 2015
Volume 21, Issue 3
Volume 21, Issue 3
Correction: First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer
Jump to section
Advertisement